Sven Poli MD
Vice Chair, Department of Neurology, University Hospital Tübingen, GermanyDr. Sven Poli is Professor of Neurology and Vice Medical Director of the Department of Neurology & Stroke at Tübingen University, Germany. His clinical expertise covers the broad spectrum of neurovascular disease ranging from prehospital management over neurocritical care to secondary stroke prevention. Since he was introduced to the field by Werner Hacke in 2006, he has been involved in clinical trials. He served as local principal investigator in more than 70 trials mainly with the indications ischemic stroke, intracranial hemorrhage, and cerebral venous thrombosis, and has been (co-)coordinating several (inter-)national projects such as ATTICUS (NCT02427126), PROOF (www.proof-trial.eu), REVISION (www.revision-trial.de) and APICES (www.apices-trial.de). He coauthored the German guidelines for secondary stroke prevention and is member of the European Stroke Organisation guideline board. Sven Poli has published over 200 articles in peer-reviewed journals of which 160 were original research articles.
Disclosures
Research support from BMS/Pfizer, Boehringer-Ingelheim, Daiichi Sankyo, European Union, German Federal Joint Committee Innovation Fund, and German Federal Ministry of Education and Research, Helena Laboratories and Werfen. Speakers’ honoraria/consulting fees from Alexion, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS/Pfizer, Daiichi Sankyo, Portola, and Werfen.